Transaction · 0000905148-26-000495

RODRIGUEZ RAUL R

RODRIGUEZ RAUL R, CEO, PRES, reported a transaction classified as exercise at RIGEL PHARMACEUTICALS INC involving 40000.000000 shares for an estimated $1096000.00. Reported holdings after the transaction were 285243.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MCEO, PRES
RIGLRIGEL PHARMACEUTICALS INC
Filing timeFeb 04
Trade dateJan 26, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$34.95
Pre-filing
1mo ago +25.9%1w ago +7.2%1d ago +5.8%
Returns since
7d -0.0%30d -17.4%90d -19.6%180d +7.1%1y +32.0%

RIGL price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
RIGL since 2026-02-04Filed 212 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0000905148-26-000495
Common Stock
Transaction date
Jan 26, 2026
Filed Feb 04, 2026, 09:20 PM · 9d delay
Shares
40.0k sh
$2.74k per share
Estimated value
$109M
Computed from shares × price
Holdings after
285k sh
Direct

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 9 calendar days after the transaction date.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Delayed Filing Direct Ownership
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CEO, President

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024.

  2. F2

    Includes 1,000 shares acquired under the Issuer's stock purchase plan.

  3. F3

    The shares vested monthly over two (2) years from January 1, 2016.

Original filing · 0000905148-26-000495
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

RIGL